Overuse of rescue medication among asthma patients is associated with increased exacerbations and higher total and asthma-related healthcare costs.
Christopher M. Blanchette, PhD
Advertisement
Articles by Christopher M. Blanchette, PhD
Compared with ipratropium alone, fluticasone/salmeterol combination therapy resulted in better clinical outcomes and similar or lower treatment costs in all COPD populations studied.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
2
5 Questions Dermatology Patients May Have About Newly-Approved Bemotrizinol
3
Venetoclax-Obinutuzumab Tops Acalabrutinib in First-Line CLL
4
Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer
5